CME Group Reports Record International Average Daily Volume of 9.2 Million Contracts in Q2 2025, Marking 18% Year-Over-Year Growth

Reuters
07-10
CME Group Reports Record International Average Daily Volume of 9.2 Million Contracts in <a href="https://laohu8.com/S/QTWO">Q2</a> 2025, Marking 18% Year-Over-Year Growth

CME Group Inc., the world's leading derivatives marketplace, reported a record international average daily volume $(ADV)$ of 9.2 million contracts for the second quarter of 2025, marking an 18% increase compared to the previous year. The growth in volume was primarily driven by record performances in the Europe, Middle East, and Africa (EMEA) region, with an ADV of 6.7 million contracts, up 15%, and the Asia Pacific (APAC) region, with an ADV of 2.2 million contracts, up 30%. In EMEA, the rise was supported by significant increases in Equity Index products, up 43%, Energy products, up 15%, Interest Rate products, up 12%, and Metals products, up 5%. Meanwhile, in APAC, the surge was attributed to a 67% increase in Energy products, a 34% rise in Metals, and a 13% growth in Agricultural products. Julie Winkler, Senior Managing Director and Chief Commercial Officer at CME Group, noted that the organization's comprehensive global benchmarks and liquidity have played a crucial role in enabling clients to manage risk effectively amidst heightened market volatility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CME Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: AQ27093) on July 10, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10